首页> 外文期刊>Biofabrication >Validation of scaffold design optimization in bone tissue engineering: finite element modeling versus designed experiments
【24h】

Validation of scaffold design optimization in bone tissue engineering: finite element modeling versus designed experiments

机译:骨组织工程中脚手架设计优化的验证:有限元建模与设计实验

获取原文
获取原文并翻译 | 示例
           

摘要

This study reports the development of biological/synthetic scaffolds for bone tissue engineering (TE) via 3D bioplotting. These scaffolds were composed of poly(L-lactic-co-glycolic acid) (PLGA), type I collagen, and nano-hydroxyapatite (nHA) in an attempt to mimic the extracellular matrix of bone. The solvent used for processing the scaffolds was 1,1,1,3,3,3-hexafluoro-2-propanol. The produced scaffolds were characterized by scanning electron microscopy, microcomputed tomography, thermogravimetric analysis, and unconfined compression test. This study also sought to validate the use of finite-element optimization in COMSOL Multiphysics for scaffold design. Scaffold topology was simplified to three factors: nHA content, strand diameter, and strand spacing. These factors affect the ability of the scaffold to bear mechanical loads and how porous the structure can be. Twenty four scaffolds were constructed according to an I-optimal, split-plot designed experiment (DE) in order to generate experimental models of the factor-response relationships. Within the design region, the DE and COMSOL models agreed in their recommended optimal nHA(30%) and strand diameter (460 mu m). However, the two methods disagreed by more than 30% in strand spacing (908 mu m for DE; 601 mu m for COMSOL). Seven scaffolds were 3D-bioplotted to validate the predictions of DE and COMSOL models (4.5-9.9 MPa measured moduli). The predictions for these scaffolds showed relative agreement for scaffold porosity (mean absolute percentage error of 4% for DE and 13% for COMSOL), but were substantially poorer for scaffold modulus (51% for DE; 21% for COMSOL), partly due to some simplifying assumptions made by the models. Expanding the design region in future experiments (e.g., higher nHA content and strand diameter), developing an efficient solvent evaporation method, and exerting a greater control over layer overlap could allow developing PLGA-nHA-collagen scaffolds to meet the mechanical requirements for bone TE.
机译:本研究报告了通过3D生物组织工程(TE)的生物/合成支架的发展。这些支架由聚(L-乳酸共聚乙醇酸)(PLGA),I型胶原蛋白和纳米羟基磷灰石(NHA)组成,试图模仿骨细胞外基质。用于加工支架的溶剂是1,1,1,3,3,3-六氟-2-丙醇。通过扫描电子显微镜,微锁定断层扫描,热重分析和非整合压缩试验,表征生产的支架。本研究还试图验证用于脚手架设计的COMSOL多发性有限元优化的使用。脚手架拓扑被简化为三个因素:NHA含量,股线直径和绞线间距。这些因素会影响脚手架承受机械负荷的能力以及结构多孔。根据I-Optimal,Split-Plot设计的实验(de)构建了二十四个支架,以产生因子响应关系的实验模型。在设计区域内,DE和COMSOL模型在其推荐的最佳NHA(30%)和股线(460μm)中同意。然而,两种方法在股线间距中不超过30%(对于德;彗星601μm)。七个脚手架是3D-Bioplopted,以验证DE和COMSOL模型的预测(4.5-9.9MPa测量的Moduli)。这些支架的预测显示了支架孔隙率的相对吻合(即,对于COMSOL的DE和13%的4%的平均绝对百分比误差),但对于支架模量基本较差(51%用于COMSOL的51%),部分原因是一些简化模型的假设。在未来的实验中扩展设计区域(例如,较高的NHA含量和链直径),显影有效的溶剂蒸发方法,并且对层重叠的更大控制施加更大的控制可以允许开发PLGA-NHA-胶原支架,以满足骨TE的机械要求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号